SLBT
SL Science Holding Limited
Price Chart
Latest Quote
$2.69
+0.09 (+3.46%)
Current Price
| Previous Close | $2.60 |
| Open | $2.58 |
| Day High | $2.75 |
| Day Low | $2.54 |
| Volume | 42,605 |
Stock Information
| Shares Outstanding | 560.76M |
| Revenue | $3.36M |
| Net Income | $-1.19M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $1.51B |
| EPS (TTM) | $-0.01 |
| Exchange | NGM |
đ Comprehensive Analysis
Company Data
| Sales | $3.36M |
| Income | $-1.19M |
Financial Ratios
| Quick Ratio | 57.02 |
| Current Ratio | 84.61 |
Returns & Margins
| ROA | -14.70% |
| ROE | -25.62% |
| Gross Margin | 57.46% |
| Operating Margin | -35.56% |
| Profit Margin | -35.42% |
Ownership
| Insider Ownership | 59.55% |
| Institutional Ownership | 0.39% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| P/S | 448.46 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $3.93 |
| SMA50 | $6.09 |
| SMA200 | $8.81 |
| RSI | 9.52 |
| ATR | 0.4032 |
| Short Float | 0.02% |
| Short Ratio | 0.03 |
| Rel Volume | 0.27 |
Performance History
| Week | -15.14% |
| Month | -43.84% |
| Quarter | -73.13% |
| 6 Months | -74.45% |
| YTD | -74.60% |
| Year | -73.86% |
| 10 Years | -73.15% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-07-30 | $2.69 | 42,605 |
| 2026-07-29 | $2.60 | 57,100 |
| 2026-07-28 | $2.75 | 38,300 |
| 2026-07-27 | $2.76 | 143,200 |
| 2026-07-24 | $3.12 | 286,600 |
| 2026-07-23 | $3.17 | 142,000 |
| 2026-07-22 | $3.35 | 109,100 |
| 2026-07-21 | $3.76 | 62,500 |
| 2026-07-20 | $3.93 | 58,100 |
| 2026-07-17 | $4.30 | 156,400 |
| 2026-07-16 | $4.33 | 41,500 |
| 2026-07-15 | $4.24 | 62,200 |
| 2026-07-14 | $4.39 | 62,000 |
| 2026-07-13 | $4.33 | 36,500 |
| 2026-07-10 | $4.73 | 111,400 |
| 2026-07-09 | $4.56 | 62,200 |
| 2026-07-08 | $4.34 | 72,800 |
| 2026-07-07 | $4.46 | 94,200 |
| 2026-07-06 | $4.72 | 332,400 |
| 2026-07-02 | $5.99 | 1,171,400 |
| 2026-07-01 | $4.45 | 284,700 |
| 2026-06-30 | $4.79 | 953,900 |
About SL Science Holding Limited
SL Science Holding Limited manufactures cosmetic skin care and scalp care products. The company's products include SL bio's milk-derived exosome essence, SL bio's tangerine-derived extract, and the MilkExo concentrate series. It also offers research services in armed T-cells, gamma delta T- cells, citrus reticulata (tangerine) extract, and milk-derived exosomes. SL Science Holding Limited was formerly known as SL BIO Co., Ltd. and changed its name to SL Science Holding Limited in June 2026. The company is based in Taipei, Taiwan.
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Revenue | |||
| Reconciled Cost Of Revenue | $1,422,187 | $1,430,842 | $140,963 |
| Cost Of Revenue | $1,422,187 | $1,430,842 | $140,963 |
| Total Revenue | $2,197,249 | $3,363,603 | $878,971 |
| Operating Revenue | $2,197,249 | $3,363,603 | $878,971 |
| Expenses | |||
| Total Expenses | $6,034,737 | $4,559,714 | $782,143 |
| Other Income Expense | $-22,636 | $17,109 | $434,430 |
| Other Non Operating Income Expenses | $-22,636 | $17,109 | $434,430 |
| Net Non Operating Interest Income Expense | $40,302 | $45,304 | $1,612 |
| Operating Expense | $4,612,550 | $3,128,872 | $641,180 |
| Selling And Marketing Expense | $0 | $1,195 | $34,256 |
| General And Administrative Expense | $2,543,528 | $1,107,331 | $606,924 |
| Income & Earnings | |||
| Net Income From Continuing Operation Net Minority Interest | $-3,819,818 | $-1,191,333 | $399,035 |
| Net Interest Income | $40,302 | $45,304 | $1,612 |
| Interest Income | $40,302 | $45,304 | $1,612 |
| Normalized Income | $-3,819,818 | $-1,191,333 | $399,035 |
| Net Income From Continuing And Discontinued Operation | $-3,819,818 | $-1,191,333 | $399,035 |
| Total Operating Income As Reported | $-3,837,488 | $-1,196,111 | $96,828 |
| Net Income Common Stockholders | $-3,819,818 | $-1,191,333 | $399,035 |
| Net Income | $-3,819,818 | $-1,191,333 | $399,035 |
| Net Income Including Noncontrolling Interests | $-3,819,818 | $-1,191,333 | $399,035 |
| Net Income Continuous Operations | $-3,819,818 | $-1,191,333 | $399,035 |
| Pretax Income | $-3,819,822 | $-1,133,698 | $532,870 |
| Interest Income Non Operating | $40,302 | $45,304 | $1,612 |
| Operating Income | $-3,837,488 | $-1,196,111 | $96,828 |
| Gross Profit | $775,062 | $1,932,761 | $738,008 |
| Per Share | |||
| Diluted EPS | - | $-0.00 | $0.00 |
| Basic EPS | - | $-0.00 | $0.00 |
| Other | |||
| Tax Effect Of Unusual Items | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-3,743,803 | $-1,148,864 | $134,019 |
| Reconciled Depreciation | $93,685 | $47,247 | $37,191 |
| EBITDA (Bullshit earnings) | $-3,743,803 | $-1,148,864 | $134,019 |
| EBIT | $-3,837,488 | $-1,196,111 | $96,828 |
| Diluted NI Availto Com Stockholders | $-3,819,818 | $-1,191,333 | $399,035 |
| Tax Provision | $-4 | $57,635 | $133,835 |
| Research And Development | $2,069,022 | $2,020,346 | $0 |
| Selling General And Administration | $2,543,528 | $1,108,526 | $641,180 |
| Other Gand A | $2,543,528 | $1,107,331 | $606,924 |
| Diluted Average Shares | - | $560,759,757 | $560,759,757 |
| Basic Average Shares | - | $560,759,757 | $560,759,757 |
Fetched: 2026-07-30
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Assets | |||
| Net Tangible Assets | $2,283,903 | $5,727,053 | $3,566,320 |
| Total Assets | $2,817,180 | $5,931,952 | $4,241,910 |
| Total Non Current Assets | $1,390,355 | $76,774 | $748,476 |
| Non Current Deferred Assets | $929,137 | $50,000 | $0 |
| Current Assets | $1,426,825 | $5,855,178 | $3,493,434 |
| Restricted Cash | $0 | $457,500 | $162,500 |
| Prepaid Assets | $38,510 | $92,599 | $1,457,438 |
| Inventory | $0 | $1,359,771 | $1,478,362 |
| Receivables | $129,699 | $265,282 | $118,280 |
| Other Receivables | $286 | $134,724 | $30,808 |
| Taxes Receivable | $129,413 | $130,558 | $60,594 |
| Cash Cash Equivalents And Short Term Investments | $1,258,616 | $3,680,026 | $276,854 |
| Cash And Cash Equivalents | $1,258,616 | $3,680,026 | $276,854 |
| Goodwill And Other Intangible Assets | - | $0 | $7,524 |
| Accounts Receivable | - | $0 | $26,878 |
| Allowance For Doubtful Accounts Receivable | - | $0 | $0 |
| Gross Accounts Receivable | - | $0 | $26,878 |
| Other Intangible Assets | - | - | $7,524 |
| Debt | |||
| Total Debt | $213,405 | $0 | $550,064 |
| Long Term Debt And Capital Lease Obligation | $64,742 | $0 | $400,477 |
| Current Debt And Capital Lease Obligation | $148,663 | - | $149,587 |
| Liabilities | |||
| Total Liabilities Net Minority Interest | $533,277 | $204,899 | $668,066 |
| Total Non Current Liabilities Net Minority Interest | $64,742 | $135,701 | $485,041 |
| Non Current Deferred Liabilities | $0 | $135,701 | $84,564 |
| Non Current Deferred Taxes Liabilities | $0 | $135,701 | $84,564 |
| Current Liabilities | $468,535 | $69,198 | $183,025 |
| Other Current Liabilities | $6,835 | $3,375 | $60 |
| Payables And Accrued Expenses | $313,037 | $65,823 | $33,378 |
| Payables | - | $6,755 | $4,489 |
| Total Tax Payable | - | $6,755 | $4,489 |
| Equity | |||
| Common Stock Equity | $2,283,903 | $5,727,053 | $3,573,844 |
| Total Equity Gross Minority Interest | $2,283,903 | $5,727,053 | $3,573,844 |
| Stockholders Equity | $2,283,903 | $5,727,053 | $3,573,844 |
| Gains Losses Not Affecting Retained Earnings | $469,437 | $228,466 | $0 |
| Other Equity Adjustments | $469,437 | $228,466 | - |
| Retained Earnings | $-5,484,378 | $-1,664,560 | $0 |
| Other Equity Interest | - | - | $3,423,844 |
| Other | |||
| Ordinary Shares Number | $560,759,757 | $560,759,757 | $560,759,757 |
| Share Issued | $560,759,757 | $560,759,757 | $560,759,757 |
| Tangible Book Value | $2,283,903 | $5,727,053 | $3,566,320 |
| Invested Capital | $2,283,903 | $5,727,053 | $3,573,844 |
| Working Capital | $958,290 | $5,785,980 | $3,310,409 |
| Capital Lease Obligations | $213,405 | $0 | $550,064 |
| Total Capitalization | $2,283,903 | $5,727,053 | $3,573,844 |
| Additional Paid In Capital | $6,931,344 | $6,795,647 | $0 |
| Capital Stock | $367,500 | $367,500 | $150,000 |
| Common Stock | $367,500 | $367,500 | $150,000 |
| Long Term Capital Lease Obligation | $64,742 | $0 | $400,477 |
| Current Capital Lease Obligation | $148,663 | $0 | $149,587 |
| Current Accrued Expenses | $313,037 | $65,823 | $28,889 |
| Net PPE | $461,218 | $26,774 | $740,952 |
| Accumulated Depreciation | $-101,661 | $-9,489 | $-33,433 |
| Gross PPE | $562,879 | $36,263 | $774,385 |
| Leases | $299,175 | $0 | - |
| Construction In Progress | $0 | $7,796 | $0 |
| Machinery Furniture Equipment | $51,380 | $28,467 | $225,558 |
| Buildings And Improvements | $212,324 | $0 | $548,827 |
| Properties | $0 | $0 | $0 |
| Finished Goods | $0 | $1,359,771 | $1,478,362 |
Fetched: 2026-07-30
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Free Cash Flow | |||
| Free Cash Flow | $-2,229,481 | $272,188 | $-2,637,245 |
| Operating Activities | |||
| Operating Cash Flow | $-1,909,796 | $280,158 | $-2,454,261 |
| Cash Flow From Continuing Operating Activities | $-1,909,796 | $280,158 | $-2,454,261 |
| Operating Gains Losses | - | $-6,250 | - |
| Investing Activities | |||
| Capital Expenditure | $-319,685 | $-7,970 | $-182,984 |
| Investing Cash Flow | $-319,685 | $123,283 | $-182,984 |
| Cash Flow From Continuing Investing Activities | $-319,685 | $123,283 | $-182,984 |
| Financing Activities | |||
| Issuance Of Capital Stock | $0 | $7,239,351 | $0 |
| Financing Cash Flow | $-879,137 | $3,066,076 | $2,860,895 |
| Cash Flow From Continuing Financing Activities | $-879,137 | $3,066,076 | $2,860,895 |
| Net Other Financing Charges | $-879,137 | $-4,173,275 | $2,860,895 |
| Net Common Stock Issuance | $0 | $7,239,351 | $0 |
| Common Stock Issuance | $0 | $7,239,351 | $0 |
| Other | |||
| Interest Paid Supplemental Data | $0 | $0 | $0 |
| Income Tax Paid Supplemental Data | $595 | $0 | $0 |
| End Cash Position | $1,258,616 | $4,137,526 | $439,354 |
| Beginning Cash Position | $4,137,526 | $439,354 | $222,867 |
| Effect Of Exchange Rate Changes | $229,708 | $228,655 | $-7,163 |
| Changes In Cash | $-3,108,618 | $3,469,517 | $223,650 |
| Net Intangibles Purchase And Sale | $0 | $3,448 | $0 |
| Sale Of Intangibles | $0 | $3,448 | $0 |
| Net PPE Purchase And Sale | $-319,685 | $119,835 | $-182,984 |
| Sale Of PPE | $0 | $127,805 | $0 |
| Purchase Of PPE | $-319,685 | $-7,970 | $-182,984 |
| Taxes Refund Paid | $-595 | $0 | - |
| Change In Working Capital | $1,661,238 | $1,265,073 | $-3,063,660 |
| Change In Other Working Capital | $-6,252 | $57,488 | $133,823 |
| Change In Other Current Liabilities | $-137,455 | $-166,609 | $-171,948 |
| Change In Payables And Accrued Expense | $246,726 | $38,620 | $25,190 |
| Change In Accrued Expense | $246,726 | $38,620 | $25,190 |
| Change In Prepaid Assets | $207,273 | $1,122,367 | $-1,531,523 |
| Change In Inventory | $1,350,946 | $187,380 | $-1,492,574 |
| Change In Receivables | $0 | $25,827 | $-26,628 |
| Changes In Account Receivables | $0 | $25,827 | $-26,628 |
| Other Non Cash Items | $155,694 | $165,421 | $173,173 |
| Depreciation Amortization Depletion | $93,685 | $47,247 | $37,191 |
| Depreciation And Amortization | $93,685 | $47,247 | $37,191 |
| Amortization Cash Flow | $0 | $3,940 | $4,067 |
| Amortization Of Intangibles | $0 | $3,940 | $4,067 |
| Depreciation | $93,685 | $43,307 | $33,124 |
| Gain Loss On Sale Of PPE | $0 | $-6,250 | $0 |
| Net Income From Continuing Operations | $-3,819,818 | $-1,191,333 | $399,035 |
Fetched: 2026-07-30